DISCONTINUED OPERATIONS

9 Months Ended

Apr. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS

On April 28, 2012, the Company entered into an asset purchase agreement (“APA”) to sell certain assets of its blood collection, filtration and processing product line (the “Product Line”) to Haemonetics Corporation (“Haemonetics”) for approximately $550,000. The transaction involved the transfer of manufacturing facilities and equipment in Covina, California; Tijuana, Mexico; Ascoli, Italy and a portion of the Company’s operations in Fajardo, Puerto Rico. In addition to the manufacturing facilities and related equipment, the Company transferred Product Line related inventory and intangible assets. Haemonetics also assumed certain employee-related liabilities. The sale closed on August 1, 2012, and approximately 1,400 employees transitioned to Haemonetics at that time.

Separate from these manufacturing facilities, the Company also agreed to transfer related blood media manufacturing capabilities and assets to Haemonetics. The transfer of the related media lines is expected to be completed by calendar year 2016. Until that time, the Company is providing these media products to Haemonetics under a supply agreement. Under the terms of the APA, approximately $535,000 was paid upon closing, with the balance of the purchase price payable upon the Company’s delivery of the aforementioned blood media manufacturing capability and related assets. Final determination of cash proceeds, gain on sale and tax impact are subject to working capital and certain other adjustments and final allocation of proceeds by jurisdiction.

The Product Line, which was a component of the Company’s Life Sciences segment, met the criteria for discontinued operations and held for sale presentation during the third quarter of fiscal year 2012 and has been reported as a discontinued operation in the Company’s condensed consolidated financial statements. The Company did not allocate any portion of the Company’s interest expense to discontinued operations.

The key components of discontinued operations for the three and nine months ended April 30, 2013 and April 30, 2012 were as follows:

	Three Months Ended					Nine Months Ended
	Apr 30, 2013			Apr 30, 2012		Apr 30, 2013		Apr 30, 2012
Net sales	$	344		$	57,180	$	8,867	$	169,493
Earnings/(loss) from discontinued operations before income taxes	$	(1,896	)	$	11,782	$	392,425	$	39,865
Provision/(benefit) for income taxes	(690		)	3,802		146,873		11,999
Earnings/(loss) from discontinued operations, net of income taxes	$	(1,206	)	$	7,980	$	245,552	$	27,866

Included in earnings from discontinued operations before income taxes above are a (loss)/gain on the sale of the Product Line of $(545) and $396,793, respectively, for the three and nine months ended April 30, 2013.

As of July 31, 2012, the aggregate components of assets and liabilities classified as held for sale in the condensed consolidated balance sheet consisted of the following:

	Jul 31, 2012
Inventory	$	40,090
Prepaid expenses and other current assets	1,883
Total current assets	$	41,973
Property, plant and equipment	$	75,506
Goodwill	18,514
Intangible assets	524
Other non-current assets	—
Total non-current assets	$	94,544
Total assets	$	136,517
Total liabilities	$	2,643